62. Malaria - A Vaccine Preventable Disease?
Session: Symposium: Vaccines for a Global Community: Meningococcus A and B, Cholera, and Malaria
Thursday, October 20, 2011: 2:00 PM
Room: 205ABC

Christian Loucq, MD, PATH Malaria Vaccine Initiative, Bethesda, MD

Dr. Loucq directs the PATH Malaria Vaccine Initiative (MVI), which seeks to accelerate the development of promising malaria vaccines and ensure their availability and use in developing countries. Dr. Loucq has more than 30 years of experience in medicine, pharmaceuticals, vaccines, and global health. He joined MVI in February 2007, serving as Director of Strategy and Operations and as Interim Director until his appointment as MVI Director three months later.
His professional experience spans the globe: Born and educated in France, he has lived and worked in Algeria, Belgium, Chad, China, India, the Netherlands, Niger, Switzerland, Thailand, and the United Kingdom. Dr. Loucq has managed vaccine businesses in China, India, and Thailand and has been involved in most stages of vaccine development. He has worked with large vaccine companies, such as GlaxoSmithKline and Sanofi Pasteur, and biotech companies including Rhein Biotech and Acambis. He has extensive experience partnering with local governments, building public-private partnerships, and setting up local private collaborations.
Dr. Loucq earned his state doctorate of human medicine at the University of Paris X and a diploma of public health and tropical medicine from the University of Aix-Marseilles.

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.